Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 3, 2012, Pages 589-597

  Chikui, Toru ^a   Kitamoto, Erina ^a   Kawano, Shintaro ^a   Sugiura, Tsuyoshi ^b   Obara, Makoto ^c   Simonetti, Arjan W ^d   Hatakenaka, Masamitsu ^e   Matsuo, Yoshio ^e   Koga, Shoichi ^b   Ohga, Masahiro ^b   Nakamura, Katsumasa ^e   Yoshiura, Kazunori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c PHILIPS RESEARCH LABORATORIES   (Germany)

^d PHILIPS HEALTHCARE   (United States)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

neoadjuvant radiotherapy; oral cancer; TK model

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CELLULAR PARAMETERS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; EXTRAVASCULAR EXTRACELLULAR SPACE; FEMALE; HUMAN; MALE; MOUTH CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OHBOSHI CLASSIFICATION; PRIORITY JOURNAL; SHIMOSATO CLASSIFICATION; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MOUTH NEOPLASMS; ORAL SURGICAL PROCEDURES; PREMEDICATION; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84865309656     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23704     Document Type: Article

References (35)

1. Adelstein DJ, Kalish LA, Adams GL, et al. Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study. J Clin Oncol 1993; 11: 2136-2142. (Pubitemid 23332249)
2. Dragovic J, Doyle TJ, Tilchen EJ, et al. Accelerated fractionation radiotherapy and concomitant chemotherapy in patients with stage IV inoperable head and neck cancer. Cancer 1995; 76: 1655-1661.
3. Benasso M, Corvá R, Numico G, et al. Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study. Anticancer Res 1995; 15: 2651-2654. (Pubitemid 26095076)
4. Klug C, Berzaczy D, Voracek M, Millesi W,. Preoperative chemoradiotherapy in the management of oral cancer: a review. J Craniomaxillofac Surg 2008; 36: 75-88.
5. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
6. Ishii A, Korogi Y, Hirai T, et al. Intraarterial infusion chemotherapy and conformal radiotherapy for cancer of the mouth: prediction of the histological response to therapy with magnetic resonance imaging. Acta Radiol 2007; 48: 900-906. (Pubitemid 47551930)
7. Tofts PS,. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7: 91-101. (Pubitemid 28365643)
8. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232. (Pubitemid 29463104)
9. Jansen JF, Koutcher JA, Shukla-Dave A,. Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma. Angiogenesis 2010; 13: 149-160.
10. Cao Y, Popovtzer A, Li D, et al. Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. Int J Radiat Oncol Biol Phys 2008; 72: 1287-1290.
11. Shukla-Dave A, Lee NY, Jansen JF, et al. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head and neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys 2012; 82: 1837-1844.
12. Kim S, Loevner LA, Quon H, et al. Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2010; 31: 262-268.
13. Chikui T, Kawano S, Kawazu T, et al. Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings. Eur Radiol 2011; 21: 1699-1708.
14. 1 relaxation estimation using limited flip angles. Magn Reson Med 1987; 5: 399-416. (Pubitemid 17167630)
15. Heilmann M, Kiessling F, Enderlin M, Schad LR,. Determination of pharmacokinetic parameters in DCE MRI: consequence of nonlinearity between contrast agent concentration and signal intensity. Invest Radiol 2006; 41: 536-543. (Pubitemid 44284189)
16. Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006; 56: 993-1000. (Pubitemid 44691341)
17. Fritz-Hansen T, Rostrup E, Larsson HB, Şndergaard L, Ring P, Henriksen O,. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996; 36: 225-231. (Pubitemid 26271742)
18. Meng R, Chang SD, Jones EC, Goldenberg SL, Kozlowski P,. Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer. Acad Radiol 2010; 17: 520-525.
19. Wang Y, Huang W, Panicek DM, Schwartz LH, Koutcher JA,. Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data. Magn Reson Med 2008; 59: 1183-1189. (Pubitemid 351590533)
20. Simonetti AW, Sunaert S, Yang P, van Muiswinkel A,. Model free bolus arrival time estimation for dynamic contrast MR studies. In: Proc 16th Annual Meeting ISMRM, Toronto; 2008, Abstract 1903.
21. Murase K,. Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med 2004; 51: 858-862. (Pubitemid 38420465)
22. Shimosato Y, Oboshi S, Baba K,. Histological evaluation of effects of radiotherapy and chemotherapy for carcinoma. Jpn J Clin Oncol 1971; 1: 19-35.
23. Oberholzer K, Pohlmann A, Schreiber W, et al. Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience. J Magn Reson Imaging 2008; 27: 1296-1301. (Pubitemid 351770680)
24. Thorwarth D, Eschmann SM, Scheiderbauer J, Paulsen F, Alber M,. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer 2005; 5: 152.
25. Jansen JF, Schöder H, Lee NY, et al. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys 2010; 77: 1403-1410.
26. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ,. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15: 621-628.
27. Vandecaveye V, Dirix P, De Keyzer F, et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010; 20: 1703-1714.
28. King AD, Mo FK, Yu KH, et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 2010; 20: 2213-2220.
29. Abbas B, Hume SP, McCullough JS, Wilson DJ, Stewart PC, Carr KE,. Early morphological changes in blood capillaries of mouse duodenal villi induced by X-irradiation. J Submicrosc Cytol Pathol 1990; 22: 609-614. (Pubitemid 20349999)
30. Jonsson K, Libshitz HI, Osborne BM,. Lymphangiographic changes after radiation therapy. AJR Am J Roentgenol 1978; 131: 803-806. (Pubitemid 9011704)
31. Abbas B, Boyle FC, Wilson DJ, Nelson AC, Carr KE,. Radiation induced changes in the blood capillaries of rat duodenal villi: a corrosion cast, light and transmission electron microscopical study. J Submicrosc Cytol Pathol 1990; 22: 63-70. (Pubitemid 20110950)
32. Akbudak E, Conturo TE,. Arterial input functions from MR phase imaging. Magn Reson Med 1996; 36: 809-815. (Pubitemid 26396807)
33. Cron GO, Foottit C, Yankeelov TE, Avruch LI, Schweitzer ME, Cameron I,. Arterial input functions determined from MR signal magnitude and phase for quantitative dynamic contrast-enhanced MRI in the human pelvis. Magn Reson Med 2011; 66: 498-504.
34. Korporaal JG, van den Berg CA, van Osch MJ, Groenendaal G, van Vulpen M, van der Heide UA,. Phase-based arterial input function measurements in the femoral arteries for quantification of dynamic contrast-enhanced (DCE) MRI and comparison with DCE-CT. Magn Reson Med 2011; 66: 1267-1274.
35. Roberts TP,. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 1997; 7: 82-90. (Pubitemid 28365642)